Amelioration of Amyloid Beta (Aβ) Neurotoxicity by Administration of Silibinin; a Behavioral and Biochemical Assessment

Overview

Journal Iran J Basic Med Sci

Publisher Mashhad University of Medical Sciences

Specialty General Medicine

Date 2023 Jul 3

PMID 37396937

Authors

Tahereh Alihosseini

Monireh Azizi

Nasser Abbasi

Shahram Mohammadpour

Maryam Bagheri

Affiliations

Soon will be listed here.

Abstract

Objectives: Alzheimer's disease (AD), the most common cause of dementia, is one of the leading causes of morbidity and death in the world. Currently, treatment mostly used to slow down the disease progression. Herbal remedies are considered by many in the community as a natural and safe treatment with fewer side effects. Silibinin, the active ingredient of , has anti-oxidant, neurotrophic and neuroprotective characteristics. Therefore, here, the effect of different doses of Silibinin extract on oxidative stress and expression of neurotrophic factors was investigated.

Materials And Methods: Forty eight male Wistar rats were randomly divided into sham, lesion; Aβ injection, lesion-treatment; Aβ injection followed by different doses of silibinin (50, 100, 200 mg / kg) through gavage and lesion-vehicle group; Aβ injection + vehicle of silibinin. Morris water Maze (MWM) was done 28 days after the last treatment. Hippocampal tissue was removed for biochemical analysis. Production of nitric oxide (NO) and reactive oxygen species (ROS), expression of BDNF/VEGF and cell viability were measured using Griess, fluorimetry, Western blotting and MTT techniques.

Results: Different concentrations of silibinin improved behavioral performance in animals. Higher doses of Silibinin could improve memory and learning function through MWM. Also, increasing the concentration of silibinin resulted in decreased ROS and NO production in a dose-dependent manner.

Conclusion: Consequently, silibinin may act as a potential candidate for alleviating symptoms of AD.

References

Mansergh F, Wride M, Rancourt D . Neurons from stem cells: implications for understanding nervous system development and repair. Biochem Cell Biol. 2000; 78(5):613-28. View

Liebl M, Kaya A, Tenzer S, Mittenzwei R, Koziollek-Drechsler I, Schild H . Dimerization of visinin-like protein 1 is regulated by oxidative stress and calcium and is a pathological hallmark of amyotrophic lateral sclerosis. Free Radic Biol Med. 2014; 72:41-54. DOI: 10.1016/j.freeradbiomed.2014.04.008. View

Cunnane S, Plourde M, Pifferi F, Begin M, Feart C, Barberger-Gateau P . Fish, docosahexaenoic acid and Alzheimer's disease. Prog Lipid Res. 2009; 48(5):239-56. DOI: 10.1016/j.plipres.2009.04.001. View

Yon B, Belviranli M, Okudan N . The effect of silymarin supplementation on cognitive impairment induced by diabetes in rats. J Basic Clin Physiol Pharmacol. 2019; 30(4). DOI: 10.1515/jbcpp-2018-0109. View

Qiu C, Kivipelto M, von Strauss E . Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention. Dialogues Clin Neurosci. 2009; 11(2):111-28. PMC: 3181909. View

Song X, Liu B, Cui L, Zhou B, Liu W, Xu F . Silibinin ameliorates anxiety/depression-like behaviors in amyloid β-treated rats by upregulating BDNF/TrkB pathway and attenuating autophagy in hippocampus. Physiol Behav. 2017; 179:487-493. DOI: 10.1016/j.physbeh.2017.07.023. View

Shen L, Liu L, Li X, Ji H . Regulation of gut microbiota in Alzheimer's disease mice by silibinin and silymarin and their pharmacological implications. Appl Microbiol Biotechnol. 2019; 103(17):7141-7149. DOI: 10.1007/s00253-019-09950-5. View

Carrillo-Mora P, Luna R, Colin-Barenque L . Amyloid beta: multiple mechanisms of toxicity and only some protective effects?. Oxid Med Cell Longev. 2014; 2014:795375. PMC: 3941171. DOI: 10.1155/2014/795375. View

Bagheri M, Rezakhani A, Roghani M, Joghataei M, Mohseni S . Protocol for Three-dimensional Confocal Morphometric Analysis of Astrocytes. J Vis Exp. 2015; (106):e53113. PMC: 4692798. DOI: 10.3791/53113. View

10.

Mateen S, Tyagi A, Agarwal C, Singh R, Agarwal R . Silibinin inhibits human nonsmall cell lung cancer cell growth through cell-cycle arrest by modulating expression and function of key cell-cycle regulators. Mol Carcinog. 2009; 49(3):247-58. PMC: 3049548. DOI: 10.1002/mc.20595. View

11.

Dos Santos V, Santos D, Lach G, Rodrigues A, Farina M, de Lima T . Neuropeptide Y (NPY) prevents depressive-like behavior, spatial memory deficits and oxidative stress following amyloid-β (Aβ(1-40)) administration in mice. Behav Brain Res. 2013; 244:107-15. DOI: 10.1016/j.bbr.2013.01.039. View

12.

Jangra A, Kasbe P, Pandey S, Dwivedi S, Gurjar S, Kwatra M . Hesperidin and Silibinin Ameliorate Aluminum-Induced Neurotoxicity: Modulation of Antioxidants and Inflammatory Cytokines Level in Mice Hippocampus. Biol Trace Elem Res. 2015; 168(2):462-71. DOI: 10.1007/s12011-015-0375-7. View

13.

Bossy-Wetzel E, Schwarzenbacher R, Lipton S . Molecular pathways to neurodegeneration. Nat Med. 2004; 10 Suppl:S2-9. DOI: 10.1038/nm1067. View

14.

Geed M, Garabadu D, Ahmad A, Krishnamurthy S . Silibinin pretreatment attenuates biochemical and behavioral changes induced by intrastriatal MPP+ injection in rats. Pharmacol Biochem Behav. 2013; 117:92-103. DOI: 10.1016/j.pbb.2013.12.008. View

15.

Bagheri M, Rezakhani A, Nystrom S, Turkina M, Roghani M, Hammarstrom P . Amyloid beta(1-40)-induced astrogliosis and the effect of genistein treatment in rat: a three-dimensional confocal morphometric and proteomic study. PLoS One. 2013; 8(10):e76526. PMC: 3793933. DOI: 10.1371/journal.pone.0076526. View

16.

Zhang H, Ma Q, Zhang Y, Xu H . Proteolytic processing of Alzheimer's β-amyloid precursor protein. J Neurochem. 2011; 120 Suppl 1:9-21. PMC: 3254787. DOI: 10.1111/j.1471-4159.2011.07519.x. View

17.

Schmitt-Schillig S, Schaffer S, Weber C, Eckert G, Muller W . Flavonoids and the aging brain. J Physiol Pharmacol. 2005; 56 Suppl 1:23-36. View

18.

Baluchnejadmojarad T, Roghani M, Mafakheri M . Neuroprotective effect of silymarin in 6-hydroxydopamine hemi-parkinsonian rat: involvement of estrogen receptors and oxidative stress. Neurosci Lett. 2010; 480(3):206-10. DOI: 10.1016/j.neulet.2010.06.038. View

19.

Stix G . Alzheimer's: forestalling the darkness. Sci Am. 2010; 302(6):50-7. DOI: 10.1038/scientificamerican0610-50. View

20.

Hou Y, Liou K, Chern C, Wang Y, Liao J, Chang S . Preventive effect of silymarin in cerebral ischemia-reperfusion-induced brain injury in rats possibly through impairing NF-κB and STAT-1 activation. Phytomedicine. 2010; 17(12):963-73. DOI: 10.1016/j.phymed.2010.03.012. View